Head of Line 3 – Innovative Technologies and Methods for Evaluation and Rehabilitation of Neurological Patients
Head of the Healthcare Innovation & Technology Laboratory

Pawel Kiper
Bio
Pawel Kiper is a researcher and specialist in the field of neurorehabilitation, currently leading Line 3 – Innovative Technologies and Methods for Evaluation and Rehabilitation of Neurological Patients, and serving as Head of the Healthcare Innovation & Technology Laboratory at IRCCS Ospedale San Camillo in Venice, Italy. He holds a degree in Physiotherapy and a Diploma in Pharmacy, and he earned a PhD in Health Sciences from Jagiellonian University Medical College in Kraków, Poland.
Throughout his career, Dr Kiper has worked in both clinical and research settings, with a focus on neurorehabilitation and innovative technologies. His research centers on using technological devices to improve motor function in individuals with neurological disorders.
His academic activities include teaching roles at several European institutions, including positions as Associate Professor at Alma Mater Europaea University (Slovenia) and Lecturer at Lunex University (Luxembourg).
In recent years, he has led and contributed to international, multicenter research projects focusing on telerehabilitation, robotic rehabilitation, and cortical plasticity. Dr Kiper has authored numerous scientific publications and received prestigious recognitions for his work, including the Seal of Excellence from the Horizon 2020 Programme.
Research Interests
Pawel’s key research interests include:
-
Analysis of brain plasticity and functional recovery following neurological injury
-
Advanced technologies for rehabilitation, including virtual reality, robotics, wearable technologies, and AI-based systems
-
Development of personalized treatment models for innovative motor and cognitive rehabilitation
-
Application of virtual reality in mental health and cardiovascular rehabilitation
-
Telerehabilitation and integrated treatment models for neurological conditions such as stroke, Parkinson’s disease, and multiple sclerosis